Bio-Reference Laboratories, Inc. (BRLI) reported fourth-quarter net income of $12.89 million or $0.46 per share, compared to $10.48 million or $0.37 per share in the comparable quarter last year.
On average, six analysts polled by Thomson Reuters expected the company to earn $0.46 per share. Analysts' estimates typically exclude special items.
The company recorded revenues of $176.05 million, up 16% from $151.30 million recorded in the fourth quarter of fiscal 2011, while five analysts expected revenue of $175.64 million for the quarter.
For comments and feedback: editorial@rttnews.com